Study

A Potential Treatment to Prevent Alzheimer’s

A New Potential for an Approved Drug

What If We Could Potentially Treat Future Alzheimer's Risk?

Charter Research is recruiting people at risk for Alzheimer’s disease to test whether a drug developed to slow the disease’s progression (donanemab) could potentially prevent it. If successful, the drug treatment would be a significant breakthrough in the fight against the disease.

“The thing that’s different about this trial compared to what people typically think about with research is it’s about prevention,” said Dr. Jeffrey Norton, medical director at Charter’s facility in The Villages. “The theory is that administration of this medication to somebody who’s been labeled at risk for Alzheimer’s disease could potentially prevent them from developing the disease.”

Who is eligible?

You may qualify for this study if:

  • You are 55-80 years old.
  • You have normal thinking and memory.
  • You have a reliable study partner.

Sign Up

Schedule Your Assessment

Sign up for an initial assessment (called a “prescreen”), and we'll give you a call. One of our professional medical staff will answer your questions and give you more information about Charter Research prior to an in-office visit.

Get More Information

Your contact information

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Locations supporting this study